Afya Ltd

Afya Ltd. is a medical education group, which engages in the provision of an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners through their medical residency preparation, post-graduate programs, and continuing medical education activities. It operates through Education Services; and Digital Content, Residency Preparatory and Specialization Programs segments. The Education Services segment provides educational services through undergraduate and graduate courses related to medicine, other health sciences, and other undergraduate programs. The Residency Preparatory and Specialization Programs segment offers digital and printed medical content services, including online courses for residency preparatory, medical and other than medical post-graduate specialization programs and mobile app subscription for digital medical content. The company was founded on March 22, 2019 and is headquartered in Nova Lima, Brazil.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Afya Ltd excels in Q2 2024 earnings, eyes growth opportunities

Afya Ltd delivered a robust performance in Q2 2024, marked by significant growth in key financial metrics, student base expansion, and strategic acquisitions.
The company's strengths lie in its strong financial position, updated guidance, operational insights, and engagement with analysts on critical industry topics.
Challenges include maintaining margins, integrating acquisitions, managing growth effectively, and adapting to potential regulatory shifts in the sector.
Opportunities for Afya include leveraging growth trends, strategic partnerships, innovation, and operational excellence to drive sustainable value creation and market leadership.

Afya Ltd reports strong Q3 earnings and eyes sustainable growth

Afya Ltd delivered a robust performance in Q3 2024, with notable revenue and EBITDA growth, demonstrating operational efficiency and financial resilience.
Despite facing challenges in a competitive landscape, the company's strategic acquisitions and focus on operational metrics provide a solid foundation for future growth.
With a strong balance sheet, improved margins, and a focus on sustainable expansion, Afya Ltd is well-positioned to capitalize on opportunities in the healthcare education sector.
Investors should monitor Afya Ltd's execution of growth strategies, operational performance, and ability to navigate challenges to assess its long-term value creation potential.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Afya (AFYA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Afya (AFYA) to Report a Decline in Earnings: What to Look Out for

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited, or Afya (Nasdaq: AFYA) today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (“MEC”) authorized the operation of the medical school in Garanhuns in the State of Pernambuco. This authorization is in connection with a previous requirement made by ITPAC, a subsidiary of Afya Participações (“Afya Brazil”), to expand their operation and open a branch in the city of Garanhuns, before the cons

Afya Limited Announces Medical School Authorization – Garanhuns - PE

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will report third quarter 2021 financial results for the period ended September 30, 2021, following the close of the market on Monday, November 22, 2021. The Company will host a corresponding conference call and webcast on November 22 at 05:00 PM EDT. A live and archived webcast of the call will be available on the Investor Relations section of the Company's website at https://ir.afya.com.br/. To p

Afya Limited to Report Third Quarter 2021 Financial Results on November 22

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited, or Afya (Nasdaq: AFYA), today announced that, after the completion of its first share repurchase program on October 21, 2021 that resulted in the purchase of 1,015,844 Class A common shares, its Board of Directors has approved a new share repurchase program. Under the share repurchase program, Afya may repurchase up to 1,383,108 of its outstanding Class A common shares in the open market, based on prevailing market prices, or in privately negoti

Afya Limited Announces Share Repurchase Program

LINC vs. AFYA: Which Stock Is the Better Value Option?

LINC vs. AFYA: Which Stock Should Value Investors Buy Now?

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited, or Afya (Nasdaq: AFYA) today announced the acquisition of 100% of the total share capital of RX PRO, a solution that connects physicians with the pharmaceutical industry, providing specialized and personalized marketing for those companies, in a more convenient way for physicians. RX PRO does this by delivering free samples to a community of pre-selected physicians and offering medical updates regarding pharmaceutical products and treatments in

Afya Limited Announces the Acquisition of RX PRO

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited or Afya (Nasdaq: AFYA) announces that Sustainalytics, a leading ESG and corporate governance research firm, has rated Afya as a “low risk” ESG Risk Rating company and in the 10th percentile in the Sustainalytics database of over 13,500 organizations as of September, 2021. Afya is at low risk of experiencing material financial impacts from ESG factors, due to its low exposure and good policies and applied practices. For further information, please

Afya's Sustainalytics ESG Risk Rating Is Publicly Available

Afya continues to outperform amid secular growth in the medical undergrad business. While near-term margin dilution could continue amid further M&A, the longer-term outlook remains compelling.

Afya: The Longer-Term Growth Story Remains Intact

LRN vs. AFYA: Which Stock Is the Better Value Option?

LRN or AFYA: Which Is the Better Value Stock Right Now?

Afya's (AFYA) CEO Virgilio Gibbon on Q2 2021 Results - Earnings Call Transcript

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA) (“Afya” or the “Company”), the leading medical education group and digital health service provider in Brazil, reported today financial and operating results for the three and six-month period ended June 30, 2021 (second quarter 2021). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Second Quarter 2021 Highlights 2Q21 Adjusted Net Revenue inc

Afya Limited Announces Second-Quarter and First Half 2021 Financial Results

Afya (AFYA) delivered earnings and revenue surprises of -85.00% and -4.84%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Afya (AFYA) Q2 Earnings and Revenues Lag Estimates

Afya (NASDAQ:AFYA) announces its next round of earnings this Thursday, August 26. Here is Benzinga's everything-that-matters guide for this Thursday's Q2 earnings announcement.

Afya's Earnings: A Preview

Afya (AFYA) Earnings Expected to Grow: Should You Buy?

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited, or Afya (Nasdaq: AFYA), hereby rectify the press release made on July 19, 2021 and announces that it will report second quarter 2021 financial results for the period ended June 30, 2021, following the close of the market on Thursday, August 26, 2021. The Company will host a corresponding conference call and webcast on August 26 at 05:00 PM EDT. To participate on the conference please follow the instructions below: Webcast: https://afya.zoom.us/j

Afya Limited to Report Second Quarter 2021 Financial Results and Host a Conference Call on August 26

NOVA LIMA, MINAS GERAIS, Brazil--(BUSINESS WIRE)--Afya Limited, or Afya (Nasdaq: AFYA), today announced that it was notified by Crescera Educacional II Fundo de Investimento em Participações Multiestrategia, or “Crescera Educacional”, of the sale of the entirety of its 23,074,134 Class B common shares of Afya to an affiliate of Bertelsmann SE& Co. KGaA, or “Bertelsmann”. Since Afya's inception, Bertelsmann has indirectly held a stake in Afya through its investment in Crescera Educacional. I

Bertelsmann Completes Acquisition of Crescera Stake in Afya; New Directors Appointed

NOVA LIMA, MINAS GERAIS, Brazil--(BUSINESS WIRE)--Afya Limited, or Afya (Nasdaq: AFYA) in addition to the Press Release released by the Company on May 27, 2021, today announced the closing of its acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Companhia Nilza Cordeiro Herdy de Eduação e Cultura (“UNIGRANRIO”). The aggregate purchase price (enterprise value) was R$700.0 million, including the assumption of estimated Net Debt of R$73

Afya Limited Announces Closing of the Acquisition of UNIGRANRIO

NOVA LIMA, MINAS GERAIS, Brazil, July 23, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or “Afya” (Nasdaq: AFYA) announced today that the resolutions set out in its Notice of Annual General Meeting dated June 28, 2021 were duly passed at its Annual General Meeting held today: (1) the approval and ratification of Afya's financial statements as of and for the fiscal year ended December 31, 2020; and (2) the approval of the Amended and Restated Memorandum and Articles of Association available at Afya's website at https://ir.afya.com.br, subject to and with effect from Closing (as that term is defined in the share purchase agreement dated on or about June 7, 2021 between Crescera Educacional II Fundo de Investimento em Participações Multiestratégia and Erste WV Gtersloh Gmbh).

Afya Limited Announces Results of Annual General Meeting Held on July 23, 2021

NOVA LIMA, Brazil, July 19, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will report second quarter 2021 financial results for the period ended June 30, 2021, following the close of the market on Thursday, August 26, 2021.

Afya Limited to Report Second Quarter 2021 Financial Results on August 26

NOVA LIMA, MINAS GERAIS, Brazil, June 07, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), today announced that it was notified by Crescera Educacional II Fundo de Investimento em Participações Multiestrategia, or “Crescera Educacional”, of the sale of the entirety of its 23,074,134 Class B common shares of Afya to an affiliate of Bertelsmann SE& Co. KGaA, or “Bertelsmann”.

Bertelsmann Acquires Crescera Stake in Afya; New Director Appointed

NOVA LIMA, Brazil, June 01, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA) in addition to the Press Release released by the Company on October 22,2020, today announced the closing of its acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Sociedade Padrão de Educação Superior Ltda (“UNIFIPMoc and Fip Guanambi”).

Afya Limited Announces Closing of the Acquisition of UNIFIPMoc and Fip Guanambi

Afya Limited (AFYA) CEO Virgilio Gibbon on Q1 2021 Results - Earnings Call Transcript

1Q21 Strong results and high-growth track record Reaffirming 1H21 guidance

News for Afya Ltd Stock (AFYA)